Home » Topics » BioWorld Science

BioWorld Science
RSS

AAV2 capsid fitness landscape allows systematic optimization of natural capsids for gene therapy

Dec. 9, 2019

Safety and efficacy of SST2 antagonist [177Lu]-satoreotide tetraxetan in advanced SST2+ NET

Dec. 9, 2019

Phase I/II trial of MERT with a CXCR4 inhibitor improves local control in glioblastoma

Dec. 9, 2019

CC-90009 shows antileukemic activity in patients with relapsed/refractory acute myeloid leukemia

Dec. 9, 2019

The brain - silicone's new frontier?

Dec. 9, 2019

ONC-201 demonstrates clinical efficacy in patients with thalamic H3 K27M-mutant glioma

Dec. 9, 2019

Epigenetic reactivation of ADGRB3 as novel therapeutic strategy in WNT-medulloblastoma

Dec. 9, 2019

Sage Therapeutics reports topline data from pivotal phase III MOUNTAIN study

Dec. 9, 2019

Positive topline data reported from phase II pozelimab in patients with PNH

Dec. 9, 2019

FDA clears IND application for a phase I study of MV-012-968 vaccine for RSV

Dec. 9, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...